acute coronary syndrome | Page 9 of 11

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Dual Antiplatelet Therapy in Diabetic Patients with AMI: De-Escalation Strategy

Dr. Andrés Rodríguez - 16 December, 2025 0

Diabetes Mellitus (DM) is a common comorbidity in patients hospitalized for acute coronary syndrome (ACS) of increasing prevalence over the last decade, associated with...

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

Dr. Omar Tupayachi - 12 December, 2025 0

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Dr. Andrés Rodríguez - 11 December, 2025 0

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: acute coronary syndrome

Follow-up at 10 years for invasive vs. conservative strategy for non-ST-segment...

FFR-Guided ACS Revascularization Apparently Superior to Culprit Vessel Treatment

Post NSTEMI Invasive Strategy Timing

Contemporary Ventricular Assist Devices: Hemodynamic Consequences

Cardiovascular Events Reduction: Bivalirudin or Heparin?

Deferring Lesions by FFR in ACS: Yes or No?

Patients with Plaque Erosion: Management without Stenting

No Extra Benefit for Combined Use of Bivalirudin and Transradial Approach

STEMI: Best P2Y12 inhibitor according to network meta-analysis

PRIME-FFR: Safe in acute coronary syndrome

Últimas Noticias

Dual Antiplatelet Therapy in Diabetic Patients with AMI: De-Escalation Strategy

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Noticias Institucionales

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Accesos